LivaNova plc (LIVN) completes CORE-VNS study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. BAC
2. NVDA
3. DPZ
4. GS
5. CRWV
6. UNH
7. ORCL
8. DRS
9. JPM
10. ACI

Go back to LivaNova plc (LIVN) completes CORE-VNS study

CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

June 5, 2025 8:15 AM EDT

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures

LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced completion of the CORE-VNS study, evaluating comprehensive outcomes of real-world evidence for... More